David Mott

David Mott

Voorzitter bij ARDELYX, INC.

Vermogen: 21 M $ op 31-05-2026

60 jaar
Health Technology
Finance
Consumer Services

Profiel

Mr. David M.
Mott
is an Independent Director at Novavax, Inc., a Chairman at Ardelyx, Inc. and a Chairman at Cydan LLC.
He is on the Board of Directors at Novavax, Inc., Biotechnology Innovation Organization, NEA 14 GP Ltd. and XTuit Pharmaceuticals, Inc. Mr. Mott was previously employed as a Chairman by Imara, Inc., an Independent Director by Clementia Pharmaceuticals, Inc., an Independent Non-Executive Director by Nightstar Therapeutics Plc, a Chairman by Adaptimmune Ltd., a Chairman by Adaptimmune Therapeutics Plc, a Chairman by Mersana Therapeutics, Inc., a Chairman-Supervisory Board by Prosensa Holding NV, a Chairman by Epizyme, Inc., a General Partner by NEA Management Co. LLC, a General Partner by New Enterprise Associates LLC, a Non-Executive Director by Shire Plc, an Executive Vice President by AstraZeneca PLC, a President by MedImmune Ventures, Inc., a Vice Chairman, President & Chief Executive Officer by MedImmune LLC, a President & Chief Executive Officer by MedImmune Ltd., a Vice President-Health Care Investment Banking by Smith Barney Harris Upham & Co., Inc., a Chairman by Complexa, Inc., a Chairman by Conceptis Technologies, Inc., a Chairman by Cydan II, Inc., a VP-Health Care Investment Banking Group by Harris Upham & Co, Inc., a Chairman by Sagimet Biosciences, Inc., a Member-Governing Board by St. Albans School, a Trustee by St. James' School, a Chairman by Vtesse, Inc., and a Chairman by Zyngenia, Inc. He also served on the board at Polyneuron Pharmaceuticals AG, Tiburio Therapeutics, Inc., Omthera Pharmaceuticals, Inc., Tesaro, Inc., Ambit Biosciences Corp., Biohealth Innovation, Inc., Edimer Pharmaceuticals, Inc., Melinta Subsidiary Corp., NightstaRx Ltd., Shire Pharmaceuticals, Inc., Shire Plc /Old/, Zosano Pharma Corp.
and ZP Opco, Inc. He received his undergraduate degree from Dartmouth College.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
16-06-2026 3.349.655 ( 1,36% ) 20 M $ 31-05-2026
23-04-2026 79.770 ( 0,05% ) 875 077 $ 31-05-2026
11-04-2025 0 ( -.--% ) - $ 31-05-2026
06-01-2026 0 ( -.--% ) - $ 31-12-2025

Actieve functies van David Mott

BedrijvenFunctieBegin
ARDELYX, INC. Voorzitter 01-03-2014
NOVAVAX, INC. Directeur/Bestuurslid 16-06-2020
Voorzitter -
NEA 14 GP Ltd.
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -

Eerdere bekende functies van David Mott

BedrijvenFunctieEinde
MERSANA THERAPEUTICS Algemeen Directeur 02-03-2015
ADAPTIMMUNE THERAPEUTICS PLC Voorzitter 14-11-2025
IMARA Voorzitter 01-02-2023
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Ervaring van David Mott in detail bekijken

Opleiding van David Mott

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

56

Eerstegraads connecties

45

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit45

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Technology Services

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Retail Trade

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

NEA 14 GP Ltd.

Health Technology

Health Technology

Distribution Services

Finance

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

  1. Beurs
  2. Insiders
  3. David Mott
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU